rediff.com

Ajanta Pharma Q3 Profit Up 11% to Rs 233 cr

Share on:

By Rediff Money Desk, New Delhi   Jan 30, 2025 18:42

Ajanta Pharma's consolidated profit after tax for Q3 FY25 rose 11% YoY to Rs 233 crore, driven by increased revenue. The company's shares closed 1.64% higher on BSE.
New Delhi, Jan 30 (PTI) Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the third quarter ended December 31, 2024.

The drug firm had reported a profit after tax (PAT) of Rs 210 crore in the October-December period of last fiscal.

Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.

Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

More »

Moneywiz Live!